Pasithea Therapeutics (KTTA) Non Operating Income (2021 - 2024)
Historic Non Operating Income for Pasithea Therapeutics (KTTA) over the last 4 years, with Q4 2024 value amounting to $81889.0.
- Pasithea Therapeutics' Non Operating Income fell 3031.79% to $81889.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $345378.0, marking a year-over-year decrease of 2676.66%. This contributed to the annual value of $345378.0 for FY2024, which is 2676.66% down from last year.
- Per Pasithea Therapeutics' latest filing, its Non Operating Income stood at $81889.0 for Q4 2024, which was down 3031.79% from $4770.0 recorded in Q3 2024.
- Pasithea Therapeutics' 5-year Non Operating Income high stood at $2.6 million for Q4 2021, and its period low was -$335317.0 during Q3 2022.
- Over the past 4 years, Pasithea Therapeutics' median Non Operating Income value was $99703.5 (recorded in 2023), while the average stood at $286569.2.
- Per our database at Business Quant, Pasithea Therapeutics' Non Operating Income tumbled by 10641.43% in 2023 and then skyrocketed by 43785.35% in 2024.
- Over the past 4 years, Pasithea Therapeutics' Non Operating Income (Quarter) stood at $2.6 million in 2021, then tumbled by 102.15% to -$55594.0 in 2022, then surged by 311.39% to $117518.0 in 2023, then tumbled by 30.32% to $81889.0 in 2024.
- Its Non Operating Income stands at $81889.0 for Q4 2024, versus $4770.0 for Q3 2024 and $78785.0 for Q2 2024.